Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial.
Saved in:
| Title: | Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial. |
|---|---|
| Authors: | Pan, Li-Xin1 (AUTHOR), Wang, Yi-Yang1 (AUTHOR), Li, Zhong-Hai1 (AUTHOR), Luo, Jia-Xi1 (AUTHOR), Wu, Kun-Jun1 (AUTHOR), Liu, Zhen-Xiu1 (AUTHOR), Wu, Pei-Sheng2 (AUTHOR), Chen, Kang3 (AUTHOR), Ma, Liang1 (AUTHOR), Fan, Xiao-Hui4 (AUTHOR) fanxiaohui63@163.com, Zhong, Jian-Hong1,5,6 (AUTHOR) zhongjianhong@gxmu.edu.cn |
| Source: | Trials. Dec2024, Vol. 25 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
